Dihydroartemisinin Sulfadoxine and Pyrimethamine Exporter, Manufacturer and Global Exporter in India

Dihydroartemisinin Sulfadoxine and Pyrimethamine Exporter, as a globally recognized we supply this formulation in strict adherence to WHO prequalification and GMP quality standards. Dihydroartemisinin Sulfadoxine and Pyrimethamine Tablet is a highly effective combination antimalarial medicine designed for the treatment of uncomplicated malaria, especially in regions where Plasmodium falciparum resistance is a major concern. This triple-therapy blend offers a synergistic effect by combining a rapid-acting artemisinin derivative with long-acting antifolate drugs, ensuring rapid parasite clearance and reducing the risk of recrudescence.

Composition and Mechanism

• Dihydroartemisinin: A potent derivative of artemisinin that quickly destroys malaria parasites during the blood stage.

• Sulfadoxine: A sulfonamide drug that blocks parasite folate synthesis, preventing multiplication.

• Pyrimethamine: An antifolate that complements sulfadoxine’s action by targeting a different step in folate metabolism.

Together, this fixed-dose combination ensures both immediate parasite clearance and extended prophylactic protection. Trusted Dihydroartemisinin Sulfadoxine and Pyrimethamine Exporters provide this therapy for both clinical and government malaria control programs worldwide.

Key Uses

• Treatment of uncomplicated Plasmodium falciparum malaria.

• Effective in areas where resistance to monotherapy is common.

• May be included in intermittent preventive treatment in pregnancy (IPTp), depending on national malaria protocols.

By sourcing from a reliable Dihydroartemisinin Sulfadoxine and Pyrimethamine Exporter, healthcare organizations and distributors ensure access to life-saving, authentic medications.

Precautions

Before starting treatment, healthcare professionals should evaluate the following:

• Allergies: Patients with hypersensitivity to sulfonamides or pyrimethamine should avoid this drug.

• Pregnancy: Though sometimes used in IPTp, administration should follow WHO and national guidelines under medical supervision.

• HIV Co-infection: Caution in patients receiving cotrimoxazole, due to increased risk of side effects.

• Liver or Kidney Impairment: Dose adjustments may be needed in compromised patients.

• Drug Interactions: Concomitant use with other folate antagonists or hematotoxic medicines should be avoided.

A reputable Dihydroartemisinin Sulfadoxine and Pyrimethamine Exporter ensures medicines are labeled with proper usage guidelines and safety information for clinicians and patients.

Possible Side Effects

Most patients tolerate this therapy well, but some may experience:

• Nausea, vomiting, or abdominal pain

• Headache, dizziness, or fatigue

• Rash or skin reactions due to sulfonamide component

• Hematological disturbances like anemia, leukopenia, or thrombocytopenia in rare cases

• Rare severe reactions such as Stevens–Johnson syndrome (very uncommon but clinically significant)

Suppliers committed to being leading Dihydroartemisinin Sulfadoxine and Pyrimethamine Exporters ensure quality testing, pharmacovigilance compliance, and transparent documentation to minimize risks.

Why Choose Us as Your Dihydroartemisinin Sulfadoxine and Pyrimethamine Exporter?

• WHO-GMP & ISO Certified production facilities.

• Regulatory compliance with pharmacopeial standards (USP, BP, IP).

• Global supply network for NGOs, hospitals, government tenders, and private distributors.

• Custom packaging and labeling available to meet export market requirements.

• Affordable pricing without compromising on therapeutic efficacy.

By partnering with us as your trusted Dihydroartemisinin Sulfadoxine and Pyrimethamine Exporter, you are assured of safe, effective, and globally compliant malaria treatment solutions that help combat one of the world’s most challenging diseases.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Dihydroartemisinin Sulfadoxine and Pyrimethamine to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.